ASAH1 and glioblastoma: In recurrent glioblastoma (GBM), elevated ASAH1 levels is observed and treatment of temozolomide (TMZ)-resistant GBM cells with carmofur resulted in decreased cell growth migration and invasion and increased apoptosis [39, 59].